Page 202 - PCC07
P. 202

   Thank you.
Don’t miss the international PCOS GL launch on
Tuesday 3.7.2018 at 10:00-11:30!
 References
(1) Alvares GA, Quintana DS, Hickie IB, Guastella AJ. Autonomic nervous system dysfunction in psychiatric disorders and the impact of psychotropic medications: a systematic review and meta‐analysis. J Psychiatry Neurosci 2016 Mar;41(2):89‐104.
(2) Bauer ME, Teixeira AL. Inflammation in psychiatric disorders: what comes first? Ann N Y Acad Sci 2018 May 11.
(3) Benson S, Hahn S, Tan S, Janssen OE, Schedlowski M, Elsenbruch S. Maladaptive coping with illness in women with polycystic ovary syndrome. J Obstet Gynecol Neonatal Nurs 2010 Jan‐Feb;39(1):37‐45.
(4) Benson S, Hahn S, Tan S, Mann K, Janssen OE, Schedlowski M, et al. Prevalence and implications of anxiety in polycystic ovary syndrome: results of an internet‐based survey in Germany. Hum Reprod 2009 Jun;24(6):1446‐1451.
(5) Bishop CV, Mishler EC, Takahashi DL, Reiter TE, Bond KR, True CA, et al. Chronic hyperandrogenemia in the presence and absence of a western‐style diet impairs ovarian and uterine structure/function in young adult rhesus monkeys. Hum Reprod 2018 Jan 1;33(1):128‐139.
(6) Cesta CE, Mansson M, Palm C, Lichtenstein P, Iliadou AN, Landen M. Polycystic ovary syndrome and psychiatric disorders: Co‐morbidity and heritability in a nationwide Swedish cohort. Psychoneuroendocrinology 2016 Nov;73:196‐ 203.
(7) Chamberlain SR, Cavanagh J, de Boer P, Mondelli V, Jones DNC, Drevets WC, et al. Treatment‐resistant depression and peripheral C‐reactive protein. Br J Psychiatry 2018 May 16:1‐9.
Page 195 of 196
202
 





















































































   200   201   202   203   204